What is "erlizumab"

n. A recombinant humanized monoclonal antibody developed to treat heart attack, stroke, and traumatic shock.

Erlizumab, also known as rhuMAb, is a recombinant humanized monoclonal antibody that was an experimental immunosuppressive drug. Erlizumab was developed by Genentech under a partnership with Roche to treat heart attack, stroke, and traumatic shock.